A Schuchat

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Group B streptococcal disease: from trials and tribulations to triumph and trepidation
    A Schuchat
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:751-6. 2001
  2. ncbi request reprint Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections
    Anne Schuchat
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Matern Child Health J 6:107-14. 2002
  3. pmc Epidemiology of group B streptococcal disease in the United States: shifting paradigms
    A Schuchat
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 11:497-513. 1998
  4. ncbi request reprint Group B streptococcus
    A Schuchat
    Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 353:51-6. 1999
  5. ncbi request reprint Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
  6. ncbi request reprint The changing epidemiology of meningococcal disease in the United States, 1992-1996
    N E Rosenstein
    Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 180:1894-901. 1999
  7. ncbi request reprint Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
    S J Schrag
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 342:15-20. 2000
  8. ncbi request reprint Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
  9. ncbi request reprint Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 188:643-52. 2003
  10. ncbi request reprint Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Group B streptococcal disease: from trials and tribulations to triumph and trepidation
    A Schuchat
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:751-6. 2001
    ..This recent triumph leaves the professional community treading lightly, alert to the need to monitor for unintended consequences that may threaten recent progress...
  2. ncbi request reprint Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections
    Anne Schuchat
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Matern Child Health J 6:107-14. 2002
    ..To determine levels of prenatal screening for several infections, intrapartum recognition of risk factors, and prophylaxis against mother-to-child transmission of group B streptococcus...
  3. pmc Epidemiology of group B streptococcal disease in the United States: shifting paradigms
    A Schuchat
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 11:497-513. 1998
    ....
  4. ncbi request reprint Group B streptococcus
    A Schuchat
    Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 353:51-6. 1999
    ..Finally, the pathogen itself has continued to evolve: new capsular serotypes described in the past decade are now causing an important proportion of clinical infections...
  5. ncbi request reprint Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
    ..Further studies are needed to better describe persons with AIDS currently developing cryptococcosis in the era of highly active antiretroviral therapy...
  6. ncbi request reprint The changing epidemiology of meningococcal disease in the United States, 1992-1996
    N E Rosenstein
    Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 180:1894-901. 1999
    ..Ongoing surveillance is necessary to determine the stability of serogroup and serosubtype distribution...
  7. ncbi request reprint Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
    S J Schrag
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 342:15-20. 2000
    ..To assess the effects of the preventive efforts, we analyzed trends in the incidence of group B streptococcal disease from 1993 to 1998...
  8. ncbi request reprint Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
    ..Empirical use of vancomycin, current prevalence of drug-resistant S. pneumoniae, and degree of nonsusceptibility to cefotaxime may have influenced these findings...
  9. ncbi request reprint Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 188:643-52. 2003
    ..HIV/AIDS was not an independent risk factor for TMP-SMZ nonsusceptibility. Vulnerability to certain serotypes among adults with HIV/AIDS may have implications in prevention strategies...
  10. ncbi request reprint Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000
    ..We conducted a retrospective case-control study to evaluate effectiveness of pneumococcal vaccine against invasive disease among adults with human immunodeficiency virus (HIV) infection in San Francisco, Calif, and Atlanta, Ga...
  11. ncbi request reprint Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
    J D Heffelfinger
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Arch Intern Med 160:1399-408. 2000
    ..To provide recommendations for the management of community-acquired pneumonia and the surveillance of drug-resistant Streptococcus pneumoniae (DRSP)...
  12. ncbi request reprint Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    J F Moroney
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:797-805. 2001
    ..Factors other than resistance, such as severity of illness at presentation and advance directive status ("do not resuscitate" orders), appear to have a stronger influence on pneumococcal pneumonia outcomes...
  13. ncbi request reprint Epidemiology of pneumococcal infections in the elderly
    J C Butler
    Arctic Investigations Program, National Center for Infectious Diseases, CDC, Anchorage, Alaska 99508, USA
    Drugs Aging 15:11-9. 1999
    ....
  14. pmc Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine
    S E Maslanka
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Immun 66:2453-9. 1998
    ..The bactericidal results show age-dependent differences in the production and retention of antibody in young children immunized with serogroup C polysaccharide; these differences are not evident with the ELISA data...
  15. ncbi request reprint Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group
    N E Rosenstein
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Obstet Gynecol 90:901-6. 1997
    ..To evaluate the potential impact of ACOG and Centers for Disease Control and Prevention (CDC) consensus strategies for the prevention of perinatal group B streptococcal disease...
  16. ncbi request reprint Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women
    D R Feikin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA
    Am J Obstet Gynecol 184:427-33. 2001
    ..CONCLUSION: Group B streptococcal colonization at delivery, but not at < or = 24 weeks' gestation, was associated with preterm delivery...
  17. ncbi request reprint The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment
    K Gay
    Departments of Medicine and of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
    J Infect Dis 182:1417-24. 2000
    ..Dissemination of the mefE determinant accounted for the rapid increase in the rate of macrolide resistance in our S. pneumoniae population...
  18. ncbi request reprint Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 35:395-402. 2002
    ....
  19. ncbi request reprint Group B streptococcal disease prevention practices of obstetrician-gynecologists
    J P Watt
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Obstet Gynecol 98:7-13. 2001
    ..To describe group B streptococcal (GBS) disease prevention practices of obstetrician-gynecologists...
  20. ncbi request reprint Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States
    J R Lingappa
    Centers for Disease Control and Prevention, Mailstop C 09, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    Vaccine 19:4566-75. 2001
    ..We evaluated the relative burdens of invasive meningococcal disease in US and examined the projected impact of various meningococcal conjugate vaccination strategies on rates of meningococcal disease...
  21. ncbi request reprint Epidemic nephritis in Nova Serrana, Brazil
    S Balter
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 355:1776-80. 2000
    ..From December, 1997, to July, 1998, 253 cases of acute nephritis were identified in Nova Serrana, Brazil. Seven patients required dialysis, and three patients died. We did a case-control study to investigate the cause of the outbreak...
  22. doi request reprint Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience
    R A Hajjeh
    Division of Bacterial Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C 25, Atlanta, GA 30333, USA
    Vaccine 28:7123-9. 2010
    ..This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines...
  23. pmc Active bacterial core surveillance of the emerging infections program network
    A Schuchat
    Centers for Disease Control and Prevention, Mailstop C23, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Emerg Infect Dis 7:92-9. 2001
    ..More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive...
  24. ncbi request reprint Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era
    K A Robinson
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, MS D 65, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    JAMA 285:1729-35. 2001
    ..Additionally, a recently licensed pneumococcal 7-valent conjugate vaccine has been recommended for use in young children and could dramatically change the epidemiology of pneumococcal disease...
  25. pmc Toxic shock syndrome in the United States: surveillance update, 1979 1996
    R A Hajjeh
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 5:807-10. 1999
    ..We reviewed surveillance data for the period 1979 to 1996, when 5,296 cases were reported, and discuss changes in the epidemiologic features of TSS...
  26. ncbi request reprint Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization
    R L Davis
    Center for Health Studies, the Clinical Planning and Improvement Division, and the Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Seattle, Washington, USA
    Am J Obstet Gynecol 184:603-10. 2001
    ..The guidelines were associated with increased maternal intrapartum antibiotic use, particularly among women at highest risk, and with a decrease in laboratory use for infants...
  27. ncbi request reprint Invasive group B streptococcal disease in Maryland nursing home residents
    K J Henning
    Epidemiology and Disease Control Program, Maryland Department of Health and Mental Hygiene, Baltimore, MD, USA
    J Infect Dis 183:1138-42. 2001
    ..Further evaluation of intra-NH transmission of GBS is warranted...